New injection could shield High-Risk moms from deadly pregnancy complication
NCT ID NCT07384936
First seen Feb 03, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study tests a drug called topefilgrastim in 100 pregnant women at high risk for preeclampsia, a serious blood pressure disorder. Participants receive either a low or high dose of the drug or standard care. The goal is to see if the drug can lower harmful protein levels in the blood and reduce the chance of developing preeclampsia or related problems like early delivery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lanzhou University Second Hospital
Lanzhou, China
Contact
Conditions
Explore the condition pages connected to this study.